All Bell ceremonies

17286779923e217-3d74-4bb5-9cdb-2d2f0fad82b5

Aelis Farma lists on Euronext Paris

Pier Vincenzo Piazza, co-founder and CEO of Aelis Farma, opens the trading day in Paris.

Aelis Farma is specialized in the research and development of drugs for the treatment of brain diseases.

The company has 2 products in clinical development, including AEF0117 for cannabis-related disorders (severe dependence, acute psychosis and acute toxicity), and AEF0217 for cognitive deficits (disorders related to Down syndrome, Fragile X syndrome, Subjective Memory Impairment (SMI) and Alzheimer's disease).

Aelis Farma lists on Euronext Paris 18/02/2022 - 16:09PM CET Paris

17262799604b5a1-812e-4e28-8946-576a834879c0

Haffner Energy lists on Euronext Growth Paris

Philippe Haffner, co-founder and CEO, and Marc Haffner, co-founder and Deputy CEO of Haffner Energy, open the trading day in Paris.

Haffner Energy is specialized in the development, project management and construction of turnkey renewable energy production stations for industrial and local authorities. The company offers the HYNOCA® process for the production of green hydrogen from biomass by thermolysis.

Haffner Energy 16/02/2022 - 9:33AM CET Paris

1726266265e05e6-caca-40ce-b855-9f51c04e2516

Medical Devices Venture lists on Euronext Access+ Paris

Loïc Poirier, CEO of Medical Devices Venture, opens the trading day in Paris.

Medical Devices Venture is an investment company specialized in acquisition of stakes in companies operating in the field of health technologies, in collaboration with SATT (Technology Transfer Acceleration Company) and researchers inventing new technologies.

Medical Devices Venture 10/02/2022 - 17:57PM CET Paris

172982865464a03-805e-494c-b007-ea73fc94c2dd

Hunyvers lists on Euronext Growth Paris

Julien Toumieux, Chairman and CEO, and Delphine Bex, Deputy CEO, of Hunyvers, open the trading day in Paris.

Hunyvers is specialized in the rental and sale of new and used mobile homes and recreational vehicles. In addition, the company offers equipment and spare parts, as well as overhaul, repair, custom fitting, installation of accessories and after-sales services.

At the end of 2021, Hunyvers has 9 concessions located in France.

Hunyvers lists on Euronext Growth Paris 02/02/2022 - 21:21PM CET Paris

1726221884be65c-9e30-4d0a-9587-534012fbf9dd

Azerion – listing & first day of trading

Atilla Aytekin and Umut Akpinar, Founders and Co-CEOs of Azerion, sounded the gong this morning to celebrate the company’s listing on the stock exchange.

Azerion’s listing is a result of the legal merger with the SPAC EFIC1, which listed on Euronext Amsterdam in 2021.

Mr Aytekin, Mr Akpinar and their team were welcomed by Simone Huis in ’t Veld, CEO of Euronext Amsterdam, and René van Vlerken, Head of Listing at Euronext Amsterdam.

Azerion 02/02/2022 - 10:03AM CET Amsterdam

17262127c4614a3-9bbc-46d6-9f3e-5b8383596923

Shell plc - First day of single line trading

Shell plc has simplified the company’s A/B share structure into a single line of ordinary shares. Today is the first day this single share line trades on Euronext Amsterdam, the London Stock Exchange and on the New York Stock Exchange (in ADR form).

To celebrate this milestone, Marjan van Loon President-Directeur Shell Nederland BV and Harry Brekelmans Executive Director Projects & Technology Shell plc sounded the gong in the Amsterdam exchange. They were welcomed by Simone Huis in ‘t Veld (CEO Euronext Amsterdam) and René van Vlerken (Head of Listing Euronext Amsterdam).

Shell plc - First day of single line trading 31/01/2022 - 12:21PM CET Europe

1726162745a6f05-f741-4cef-9982-9742f8ab9b53

Hopium lists on Euronext Growth Paris

Olivier Lombard, CEO and Founder of Hopium, opens the trading day in Paris.

Hopium is specialized in the construction of high-end hydrogen-powered vehicles.

Hopium 20/01/2022 - 16:22PM CET Paris

17261236a58023a-29f6-4d71-9723-b1f0aa2b79bd

Iervolino & Lady Bacardi Entertainment S.p.A lists on Euronext Growth Paris

Andrea Iervolino, President & Chief Executive Officer of Iervolino & Lady Bacardi Entertainment S.p.A, opens the trading day in Paris.

Iervolino & Lady Bacardi Entertainment S.p.A. (formerly Iervolino Entertainment S.p.A.) specializes in the production and marketing of cinematographic and television content (films, television shows, web series, etc.).

Iervolino & Lady Bacardi Entertainment S.p.A 12/01/2022 - 9:23AM CET Paris

17259071dd944ad-8c91-40e1-b6d9-fabf0681ba2a

Toosla lists on Euronext Growth Paris

Eric Poncin, Co-Founder & Chief Executive Officer, and  Panayotis Staïcos, Deputy Managing Director, open the trading day in Paris.

Toosla is specialized in short-term rental of high-end vehicles. Serving both businesses and individuals, the company’s business activity is carried out over a mobile platform that lets users rent vehicles online without going through an agency, and have their vehicle delivered to their home or pick it up at any time at one of the company’s approved stations.

Toosla 20/12/2021 - 10:35AM CET Paris

172586042b3a98d-1ba0-4c80-8577-00453ac697b4

Groupe Berkem lists on Euronext Growth Paris

Olivier Fahy, Founder & Chief Executive Officer, opens the trading day in Paris.

Berkem Group is a chemical group organized around 4 business units:

• Production of active ingredients: from the extraction of plant materials. In addition, the group offers freeze-drying services for the food, cosmetics, nutraceutical and pharmaceutical industries, etc.;
• Formulation of solutions for the preservation and protection of materials: in particular wood materials;
• Distribution of solutions for the treatment, machining and protection of wood materials;
• Manufacture of alkyd resins: for the paint, construction, wood treatment and ink industries.

At the end of 2020, the company has 4 production sites located in France.

Groupe Berkem 08/12/2021 - 13:09PM CET Paris

172585402da5e65-9b53-4835-9162-3765de356598

Group SFIT lists on Euronext Access + Paris

Stephan Français, Chief Executive Officer of Group SFIT, closes the trading day in Paris.

Group SFIT is specialized in the design and marketing of laptops, tablets and computer accessories sold under exclusive Thomson brand license.

Group SFIT 06/12/2021 - 19:50PM CET Paris

17258463aa2ae55-7f59-4903-bdc0-1da760308076

Grolleau lists on Euronext Growth Paris

Laurent Marbach, Chief Executive Officer of Grolleau, opens the trading day in Paris.

Grolleau S.A. is specialized in the design, manufacture and marketing of metal cabinets for use in utility infrastructure (telecommunications, green energy, industries etc.).

At the end of 2020, the group had one production site located in France.

Grolleau lists on Euronext Growth Paris 03/12/2021 - 16:25PM CET Paris

1725753d3c7a6ad-45f3-4d7e-b830-ac391bf14116

FARE Capital – Launch and first investment of FARE Capital Impact Fund

Today, Mike de Leeuw, CEO of My Life Technologies, sounded the gong to celebrate the first investment of the FARE Capital Impact Fund. The fund of FARE Capital has invested in My Life Technologies, which produces and develops a special technique where drugs are delivered through the skin. The group was welcomed by Lennart Visser, Junior Product Manager and Robin van Rijn, Client Relationship Manager of Euronext Amsterdam.

FARE Capital Impact Fund 12/11/2021 - 9:07AM CET Amsterdam

1725750b1c3a01e-c8bf-4ad4-9e20-e60554c83f9c

SPEAR Investments I B.V. – SPAC listing and first day of trading

Jorge Lucaya, Co-Chief Executive Officer of SPEAR Investments I B.V., sounded the gong this morning on the occasion of the listing of SPEAR Investments I B.V., a Special Purpose Acquisition Company (SPAC). He was welcomed by René van Vlerken, Head of Listing at Euronext Amsterdam.

SPEAR Investments I B.V. 11/11/2021 - 9:43AM CET Amsterdam

172574389de726f-3c95-4dfa-a080-78a9f5f9c2a9

MaaT Pharma lists on Euronext Paris

Hervé Affagard, co-Founder and Chief Executive Officer, opens the trading day in Paris.

MaaT Pharma is specialized in the research and development of microbiome biotherapies for use in the treatment of solid cancer tumors (in particular, acute myeloid leukemia) and acute graft-versus-host disease (GvHD).

The company has 3 products in the development phase.

MaaT Pharma 09/11/2021 - 9:33AM CET Paris

1725642596b6608-6083-4de4-a98d-5923a8b89f08

MotorK – Listing and first day of trading

Marco Marlia, CEO of MotorK, sounded the gong together with his team to celebrate the listing of his company this morning. They were welcomed by René van Vlerken, Head of Listing at Euronext Amsterdam. MotorK is a technology company that delivers ‘software-as-as-service’ for the automotive retail industry. This includes sales software and CRM packages that support the full life cycle of the vehicle and help manage the customer journey.

MotorK 05/11/2021 - 9:21AM CET Amsterdam

1725632be09e6d4-1046-4232-ba5d-34d1d78728c4

Forsee Power lists on Euronext Paris

Christophe Gurtner, Founder, Chairman & Chief Executive Officer of Forsee Power, opens the trading day in Paris. Forsee

Power is specialized in the design, manufacture and marketing of smart battery systems for use in the electric mobility market. Net sales break down by activity as follows:

• sale, installation and activation of lithium-ion battery systems (93.8%): systems for use in light electric vehicles (electric bicycles, scooters and light 1- to 4-wheel vehicles), heavy vehicles (farming, construction and industrial vehicles, trucks, buses, rail vehicles, and ships), stationary energy storage units (for residential, commercial and industrial purposes), medical equipment, connected objects, home systems, robotics equipment and work tools;
• provision of services (5.5%): financing services (battery rentals), battery life cycle management services and after-sales services;
• other (0.7%). At the end of 2020, the group had 4 production sites located in France, Poland, India and China. TNet sales are distributed geographically as follows: France (71.9%), Europe (17.6%), Asia (6.2%), the United States (3.2%) and other (1.1%).

Forsee Power 03/11/2021 - 15:03PM CET Paris

1725620e9417a85-b41e-4060-81db-e550a8db6d2a

Acticor Biotech lists on Euronext Growth Paris

Gilles Avenard, Chief Executive Officer, opens the trading day in Paris.

Acticor Biotech is specialized in the research and development of medicines for the treatment of thrombotic diseases, in particular acute ischemic strokes and pulmonary embolisms.

The group has one product in Phase II clinical development (Glenzocimab).

Acticor Biotech 02/11/2021 - 14:26PM CET Paris